We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
+14.94%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$114B
AUM Growth
+$18.7B
Cap. Flow
+$1.27B
Cap. Flow %
1.11%
Top 10 Hldgs %
12.43%
Holding
4,806
New
575
Increased
1,549
Reduced
1,464
Closed
527

Sector Composition

Rank Sector Weight
1 Technology 17.03%
2 Consumer Discretionary 9.51%
3 Healthcare 5.76%
4 Financials 5.47%
5 Communication Services 4.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDT icon
1226
PUT
Medtronic
MDT
$109B
$10.3M 0.01%
+125,000
New +$9.53M
MPWR icon
1227
PUT
Monolithic Power Systems
MPWR
$64.3B
$10.3M 0.01%
16,300
+15,800
+3,160% +$8.25M
ACHC icon
1228
Acadia Healthcare
ACHC
$3B
$10.3M 0.01%
132,013
+29,423
+29% +$2.18M
WING icon
1229
PUT
Wingstop
WING
$3.76B
$10.3M 0.01%
40,000
-10,000
-20% -$2.16M
TSN icon
1230
CALL
Tyson Foods
TSN
$21.7B
$10.3M 0.01%
190,800
+112,200
+143% +$5.45M
KMI icon
1231
Kinder Morgan
KMI
$71B
$10.2M 0.01%
581,045
-2,290,634
-80% -$39M
LEGN icon
1232
Legend Biotech
LEGN
$3.69B
$10.2M 0.01%
170,129
-16,007
-9% -$1.01M
WST icon
1233
West Pharmaceutical
WST
$23.2B
$10.2M 0.01%
+29,044
New +$10.3M
SYY icon
1234
Sysco
SYY
$40.1B
$10.2M 0.01%
139,714
-23,548
-14% -$1.63M
MTX icon
1235
Minerals Technologies
MTX
$2.27B
$10.2M 0.01%
143,114
+17,150
+14% +$1.02M
STM icon
1236
STMicroelectronics
STM
$46.6B
$10.2M 0.01%
203,442
-352,377
-63% -$15.8M
CLX icon
1237
CALL
Clorox
CLX
$11.8B
$10.2M 0.01%
71,500
+20,000
+39% +$2.67M
TTEC icon
1238
TTEC Holdings
TTEC
$109M
$10.2M 0.01%
469,883
+214,636
+84% +$4.52M
AMR icon
1239
CALL
Alpha Metallurgical Resources
AMR
$1.83B
$10.2M 0.01%
30,000
-200
-0.7% -$52.7K
BCE icon
1240
BCE
BCE
$20B
$10.2M 0.01%
258,213
+158,437
+159% +$6.13M
PLUG icon
1241
CALL
Plug Power
PLUG
$2.85B
$10.2M 0.01%
2,255,900
+154,500
+7% +$810K
MKC icon
1242
McCormick & Company Non-Voting
MKC
$13.7B
$10.1M 0.01%
147,928
-99,835
-40% -$6.53M
PLD icon
1243
Prologis
PLD
$136B
$10.1M 0.01%
75,891
-171,662
-69% -$19.5M
SKWD icon
1244
Skyward Specialty Insurance
SKWD
$2.48B
$10.1M 0.01%
298,115
+218,611
+275% +$6.72M
RUN icon
1245
CALL
Sunrun
RUN
$2.33B
$10.1M 0.01%
514,300
-48,900
-9% -$620K
CVS icon
1246
CVS Health
CVS
$136B
$10.1M 0.01%
127,741
-744,310
-85% -$53M
ILMN icon
1247
PUT
Illumina
ILMN
$28.7B
$10.1M 0.01%
74,427
+28,167
+61% +$3.25M
CRSP icon
1248
CALL
CRISPR Therapeutics
CRSP
$4.65B
$10.1M 0.01%
160,900
+68,400
+74% +$3.78M
BEKE icon
1249
CALL
KE Holdings
BEKE
$17.2B
$10.1M 0.01%
+620,500
New +$9.6M
MOS icon
1250
CALL
The Mosaic Company
MOS
$7.03B
$10.1M 0.01%
281,400
+53,700
+24% +$1.9M

Similar funds

D.E. Shaw & Co's Q4 2023 Portfolio in Review

As of Q4 2023, D.E. Shaw & Co held 4,806 positions worth $114B, up 19% from $95.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

D.E. Shaw & Co's Q4 2023 filing shows 575 new, 1,549 increased, 1,464 reduced and 527 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $546M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • D.E. Shaw & Co's largest Q4 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M.
  • D.E. Shaw & Co added most to Netflix in Q4 2023, an estimated $751M increase.
  • D.E. Shaw & Co's biggest Q4 2023 reduction was Microsoft, cutting an estimated $336M.
  • D.E. Shaw & Co fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $546M.
  • D.E. Shaw & Co's ten largest holdings make up 12% of its $114B portfolio in Q4 2023.
  • D.E. Shaw & Co opened 575 new positions and closed 527 in Q4 2023.
  • D.E. Shaw & Co's portfolio value rose 19% quarter-over-quarter to $114B.

Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.